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Abstract
The spread of Chronic Wasting Disease (CWD) in the deer and elk population has caused serious public health 
concerns due to its potential to infect farm animals and humans. Like other prion disorders such a sporadic Creutzfeldt-
Jakob-disease of humans and Mad Cow Disease of cattle, CWD is caused by PrP-scrapie (PrPSc), a β-sheet rich isoform of 
a normal cell surface glycoprotein, the prion protein (PrPC). Since PrPSc is sufficient to cause infection and neurotoxicity 
if ingested by a susceptible host, it is important to understand the mechanism by which it crosses the stringent 
epithelial cell barrier of the small intestine. Possible mechanisms include co-transport with ferritin in ingested food and 
uptake by dendritic cells. Since ferritin is ubiquitously expressed and shares considerable homology among species, 
co-transport of PrPSc with ferritin can result in cross-species spread with deleterious consequences. We have used a 
combination of in vitro and in vivo models of intestinal epithelial cell barrier to understand the role of ferritin in 
mediating PrPSc uptake and transport. In this report, we demonstrate that PrPSc and ferritin from CWD affected deer and 
elk brains and scrapie from sheep resist degradation by digestive enzymes, and are transcytosed across a tight 
monolayer of human epithelial cells with significant efficiency. Likewise, ferritin from hamster brains is taken up by 
mouse intestinal epithelial cells in vivo, indicating that uptake of ferritin is not limited by species differences as 
described for prions. More importantly, the iron content of ferritin determines its efficiency of uptake and transport by 
Caco-2 cells and mouse models, providing insight into the mechanism(s) of ferritin and PrPSc uptake by intestinal 
epithelial cells.
Background
Prion disorders are a group of neurodegenerative condi-
tions of humans and animals that are known to be trans-
mitted through ingestion of prion contaminated material.
This mode of transmission was described historically as
'Kuru', a neurodegenerative condition of humans
acquired by ingesting prion disease affected human brain
tissue [1,2]. Later, the disease was transmitted to humans
from diseased cows, referred to as variant Creutzfeldt-
Jakob disease (vCJD) [3-5]. Despite convincing evidence
of its transmission through contaminated food, the
mechanism by which PrP-scrapie (PrPSc), the principal
pathogenic and infectious agent responsible for all prion
disorders crosses the stringent epithelial cell barrier has
remained enigmatic. Transport through dendritic cells,
M cells, and co-transport in association with ferritin has
been reported, but a complete understanding of either
pathway is lacking [6-8].
PrPSc is a β-sheet rich isoform of a normal cell surface
glycoprotein, the prion protein (PrPC) that acquires cer-
tain biochemical characteristics such as insolubility in
non-ionic detergents, tendency to aggregate, limited
resistance to digestion by proteinase-K, and the ability to
replicate [9]. Most infectious prion disorders are acquired
when PrPSc from an exogenous source gains access to the
central nervous system and induces the conversion of
host PrPC to its own conformation. A certain amount of
homology between the incoming PrPSc and host PrPC is
required for efficient conversion, explaining the protec-
tive influence of species barrier such as between rodents
and humans [10]. However, the possible transmission of
sheep scrapie to cattle and onward transmission to
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humans indicates that non-homologous PrPSc can be car-
ried by certain hosts, and in some cases, convert host
PrPC to a novel PrPSc conformation, albeit very slowly [11-
1 3 ] .  I n  vi ew  o f  t h e s e  f a c t s,  i t  i s  i m po rt a n t  t o  ev a l u a t e
whether PrPSc from deer and elk population infected with
CWD can cross the species barrier and create a carrier
state in cattle sharing the same grazing ground, or
through contaminated food products in humans [14-17].
Since the most likely source of natural infection with
CWD and other prion disorders is through ingestion of
PrPSc contaminated food, it is important to understand
the mechanism by which PrPSc, a protein of 27-37 kDa
survives the harsh digestive environment and crosses the
stringent epithelial cell barrier while retaining its infec-
tious nature. The resilience of PrPSc to digestive enzymes
is shared with ferritin, an iron storage protein that is a
common constituent of all foods. In a previous report we
demonstrated that PrPSc forms a relatively stable complex
with ferritin in prion disease affected brain homogenates,
and the complex is transcytosed together across a mono-
layer of Caco-2 cells, an in vitro model of human epithe-
lial cell barrier [7,18,19]. Since ferritin shares significant
homology across species, PrPSc from distant species is
likely to ride 'piggy back' on ferritin to cross the epithelial
cell layer, raising the possibility that infectious PrPSc from
distant species such as deer and elk could cross the intes-
tinal epithelial barrier of cattle or humans, and create a
carrier state [20,21].
To evaluate this possibility, we have checked the trans-
port of ferritin from different species across a tight
monolayer of Caco-2 cells, and confirmed our observa-
tions in vivo in mouse models. We report that brain ferri-
tin from three different cases of CWD and sheep scrapie
resists degradation by digestive enzymes (DE) and is
associated with PrPSc. Both ferritin and PrPSc from dis-
eased CWD and sheep brains are transported across a
monolayer of Caco-2 cells, and the iron content of ferritin
determines its efficiency of uptake and transport by
Caco-2 cells in vitro, and by mouse intestinal epithelial
cells in vivo. These observations have significant implica-
tions for inter-species spread of CWD and other animal
prion disorders.
Methods
Chemicals and antibodies
Anti-PrP antibody 3F4 was obtained from Signet Labora-
tories (Dedham, MA, USA), anti-ferritin antibody from
Sigma (St. Louis, MO, USA), anti-zonula occludens-1
(ZO-1) from Zymed (San Francisco, CA, USA), and
horseradish peroxidase (HRP)-conjugated secondary
antibodies were obtained from GE Healthcare (Little
Chalfont, Buckinghamshire, UK). Goat anti-Rabbit FITC
(fluorescein isothiocyanate) and TRITC (tetramethylrho-
damine B isothiocyanate) labeled secondary antibodies
were from Southern Biotechnology Associates (Birming-
ham, AL, USA). Sulfo-NHS-biotin and streptavidin-Texas
Red were purchased from Pierce (Rockford, IL, USA). All
cell culture supplies were obtained from Invitrogen
(Carlsbad, CA, USA). Nuclear stain Hoechst 33342 was
obtained from Molecular Probes (Eugene, OR, USA).
Radiolabeled  59FeCl3 was purchased from Perkin Elmer
(Boston, MA, USA). All other reagents including desfer-
roxamine (DFO) were procured from Sigma.
Preparation of brain homogenates, treatment with DE and 
proteinase K and immunoprecipitation
A 10% homogenate of normal, CWD, sheep scrapie, or
sporadic CJD (sCJD) brain tissue was prepared in phos-
phate buffered saline (PBS, pH 7.4) by sonication on ice.
In vitro digestion with enzymes was carried out as
described in a previous report [7]. Briefly, 0.5 ml of
homogenate was incubated with 200 U of salivary amy-
lase for 15 min at 37°C. The pH of the mixture was
adjusted to 2.0 with 5 M HCl followed by addition of 50 μl
of pepsin (4095 U) and incubation for 1 h at 37°C. Subse-
quently, the pH was raised to 6.0 with 1 M sodium bicar-
bonate and 0.2 ml of pancreatin-bile extract was added
(1.85 mg of pancreatin and 11 mg of bile extract/ml of 0.1
M NaHCO3). After raising the pH to 7.4 with 6N NaOH,
8.4 μl each of 2 M NaCl and KCl solutions were added
and the mixture was rocked for additional 2 h at 37°C.
Digestive enzymes were inactivated by the addition of
PMSF and protease inhibitors and samples were stored at
-70°C till further use.
For PK treatment, the homogenate was mixed with
equal volume of 2× lysis buffer (20 mM Tris-HCl; pH 7.4,
100 mM NaCl, 10 mM EDTA, 1% NP-40, and 0.5%
sodium deoxycholate) and incubated with 50 μg/ml of
proteinase K (PK) for 1 h at 37°C. The reaction was
stopped by the addition of PMSF and protease inhibitor
cocktail. For co-immunoprecipitation studies, untreated
o r  P K -  o r  D E - t r e a t e d  n o r m a l  h o m o g e n a t e  ( N H )  a n d
sCJDH samples were immunoprecipitated with anti-fer-
ritin antibody as described previously, and eluted pro-
teins were subjected to Western blotting and probed with
8H4, a monoclonal antibody specific to PrP [7].
Transport of PrPSc across Caco-2 monolayers
Caco-2 cells were cultured as described in an earlier
report [7]. In short, cells were resuspended in DMEM at a
density of 2 × 108 cells/ml and added to the apical cham-
ber (AP) chamber of poly-carbonate filters (Trans-well;
12 or 24 mm diameter; 3 μm pore size; Costar, Cam-
bridge, MA) coated with collagen. The filters were placed
in a 12- or 6-well culture dish containing 0.6 or 1.2 ml of
DMEM respectively. The medium was replaced every day
until the development of confluent monolayers with tightSunkesula et al. Molecular Brain 2010, 3:14
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junctions (10-14 days). The integrity of tight junctions
was monitored by measuring trans-epithelial electrical
resistance (TEER) across the monolayer with a millicell-
ERS instrument (Millipore, Bedford, MA). Monolayers
exhibiting a TEER of > 400 Ώ/cm2 were used for trans-
port studies.
To evaluate ferritin and PrPSc transport, Caco-2 mono-
layers were washed with serum-free medium, and 20 μl of
sample diluted in 1 ml of serum-free medium was added
to the AP chamber. The inserts were placed in a 6-well
dish containing 1.2 ml of serum-free medium. After an
overnight incubation at 37°C, medium from AP and baso-
lateral (BL) chambers were collected, clarified for cell
debris, and proteins were precipitated with cold metha-
nol. Precipitated protein were boiled in sample buffer,
immunoblotted, and detected with specific antibodies as
described below.
Radiolabeling of cellular ferritin with 59FeCl3 and transport
Radiolabeling of mouse neuroblastoma N2a cells was per-
formed essentially as described previously [22]. Briefly,
N2a cells cultured to 80% confluence were incubated in
serum free medium for 1 h followed by incubation with
59FeCl3-citrate complex (1 mM sodium citrate and 20-25
μCi of 59FeCl3 in serum free Opti-MEM) for 4 h at 37°C.
Following the incubation, cells were washed with ice cold
PBS and lysed in PBS or native lysis buffer (0.14 M NaCl,
0.1 M HEPES, pH 7.4, 1.5% Triton X-100 and 1 mM
PMSF). The amount of radioactivity incorporated was
determined in cell lysates by γ-counting.
All animal procedures were performed as per guide-
lines established by the Animal Resource Center, Case
Western Reserve University, and were based on protocols
approved by the IACUC committee. Mice were fed with
free  59FeCl3  or  59FeCl3-labeled N2a homogenates as
described in a previous report [23]. In short, Four months
old FVB/NJ mice (Jackson Laboratory) were fasted over-
night with water ad libitum and equal counts (300,000) of
either free 59FeCl3 mixed with N2a cell homogenate or
59FeCl3 labeled N2a homogenates in (PBS) were adminis-
tered orally using an olive-tipped gavage needle. After a
chase of 4 h, mice were euthanized and blood was col-
lected in heparinized vials. Brain, liver, spleen, and upper
gastro-intestinal tract were harvested, washed with PBS,
and snap frozen on dry ice. The organs were weighed, and
incorporated radioactivity was counted in a γ-counter.
Proximal region (1-2 cm) of duodenum was homogenized
in native lysis buffer and analyzed for 59Fe labeled ferritin
after resolving on native gradient gel followed by autora-
diography. Native gradient gel electrophoresis of duode-
num homogenates or N2a cell lysates for 59Fe-ferritin
analysis was done as described by Vyoral et al. [24] with
modification as in previous reports [22,23].
Uptake of biotinylated proteins by mouse intestinal 
epithelium
Proteins in brain homogenates were biotinylated by add-
ing 1 mg/ml EZ-Link Sulfo-NHS-Biotin followed by an
overnight incubation on a rocking platform at 4°C. Bioti-
nylated proteins were concentrated using methanol and
suspended in 1 ml of 10% normal brain homogenate. Por-
cine bile extract was added to the suspended homogenate
(11 mg of bile extract/ml of 0.1 M NaHCO3, pH 7.4), and
contents were sonicated on ice. This comprised the con-
trol sample (-DFO). To deplete the sample of iron, brain
homogenate was supplemented with iron chelator DFO
(30 μM) and rocked for 1 h at 4°C. Following extensive
dialysis against PBS at 4°C to remove DFO-iron com-
plexes, the homogenate was biotinylated and prepared as
above, and labeled as +DFO sample. FVB/NJ mice
starved overnight were fed 0.2 ml of -DFO or +DFO
homogenates by gastric gavage as above. After a chase of
2 h, the mice were sacrificed, and segments of intestine
were processed for cryosectioning in Tissue tek OCT
compound (Sakura Finetek USA Inc; Torrance, Califor-
nia) and snap frozen in isopentane cooled in Liquid nitro-
gen. Sections were cut at 5-10 μm thickness and
immunostained.
Immunofluorescence staining
Sections of mouse intestine were permeabilized with cold
acetone at -20°C for 1 min and fixed in methanol for 20
min at -20°C. After rinsing with PBS, sections were incu-
bated for 30 min in blocking buffer (PBS containing 3%
non immune goat serum) at room temperature. Subse-
quently, sections were incubated with Streptavidin-Texas
red diluted 1:40 in blocking buffer for 40 min at 37°C in a
humidified chamber followed by three quick rinses and
incubation with polyclonal anti-ferritin (1:10) antibody
followed by goat anti rabbit FITC-conjugated secondary
antibodies (1:20) for 40 min each. The sections were
rinsed in PBS and incubated with monoclonal anti-ZO-1
(1:10) followed by anti-mouse TRITC conjugated second-
ary antibody (1:20). Stained sections were incubated with
Hoechst 33342 (1 μg/ml) for 5 min to detect nuclei and
mounted in Gel-mount (Biomeda Corp., Foster City, CA).
Sections were then imaged by a fluorescent microscope.
For immunostaining M17 cells, sub-confluent cultures
were exposed to 5 μl of control or iron depleted samples,
incubated for the indicated time, and processed for
immunostaining as described in previous reports [25].
Detection of Iron
Prussian blue reaction was performed to detect iron in
brain homogenates as described by Smith et al. [26]. In
brief, homogenates spotted on a PVDF membrane were
immersed in a mixture of acidified potassium ferro- and
ferri-cyanide solution (7%) for 20 min followed by wash-Sunkesula et al. Molecular Brain 2010, 3:14
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ing with deionized water. Blue color indicated reactive
iron.
SDS-PAGE and Western blotting
Proteins were processed for SDS-PAGE and Western
blotting as described previously [27,28]. Proteins trans-
ferred to PVDF membranes were probed with anti-PrP
8H4 (1:3000) or anti-ferritin antibody (1:1000) followed
by horseradish peroxidase conjugated secondary anti-
body (1:6000). Immunoreactive bands were visualized by
ECL detection system (Amersham Biosciences Inc.).
Results
CWD and sheep PrPSc resist in vitro digestion and are 
associated with ferritin
Ingested food is subjected to a series of enzymatic reac-
tions beginning with salivary amylase, stomach pepsin,
pancreatic enzymes, and bile before absorption by intes-
tinal epithelium. Most proteins are degraded into smaller
peptides by this process to facilitate absorption. To evalu-
ate whether PrPSc from CWD affected deer and elk brains
and sheep scrapie resist degradation by digestive enzymes
(DE), brain homogenates from four cases of CWD and
one case of sheep scrapie were processed for in vitro
digestion as described [7,29]. Digestion was stopped by
addition of protease inhibitors followed by boiling in
sample buffer, and 5 and 10 μl aliquots of first three CWD
cases and 15 μl aliquots of CWD-4 and sheep samples
were fractionated by SDS-PAGE and subjected to West-
ern blotting. Probing with anti-PrP monoclonal antibody
8H4 shows cleaved PrP forms that migrate between 19
and 27 kDa, typical of PK-resistant glycosylated and ung-
lycosylated PrPSc  that accumulates in diseased brains
(Figure 1A, lanes 1-8). Although the total amount of PrPSc
is higher in CWD-4 and sheep samples as expected, there
is no measurable effect on cleavage efficiency by DE, indi-
cating that majority of PrPSc is cleaved by this procedure
(Figure 1A, lanes 7 and 8). These results suggest that a
significant amount of infectious PrPSc from CWD and
sheep brains escapes digestion, and is available for uptake
by intestinal epithelial cells.
To evaluate whether PrPSc from CWD affected brains
forms a complex with ferritin as reported for sCJD [7],
control and DE treated homogenates from normal (NH),
sCJD (CJDH), and CWD-4 sample were immunoprecipi-
tated with anti-ferritin antibody and checked for co-
immunoprecipitation of PrP by Western blotting (Figure
1B). Following an overnight incubation with anti-ferritin
antibody, protein-antibody complexes were captured
with protein-A beads and washed using stringent condi-
tions. Antibody-protein complexes eluted from beads
(bds) and unbound proteins in the supernatant (sup) were
fractionated by SDS-PAGE, subjected to Western blot-
ting, and probed for PrP with 8H4. A significant amount
of PrP from control (DE-) and faster migrating PrPSc from
DE treated (DE+) CJDH and CWD-4 samples co-immu-
noprecipitates with ferritin (Figure 1B, lanes 2, 6, 8, 10,
and 12). As expected, no PrP is detected in DE+ NH sam-
ples (Figure 1B, lanes 3 and 4, *), and in the supernatant of
DE+ CJDH and CWD-4 samples (Figure 1B, lanes 7 and
11). Full-length PrP migrating between 27-37 kDa is
detected in the supernatant and bead fractions of
untreated NH, CJDH, and CWD-4 samples, indicating
co-immunoprecipitation of normal (PrPC) and uncleaved
PrPSc with ferritin (Figure 1B, lanes 1-2, 5-6, and 9-10).
No PrP forms were detected in any sample in the absence
of anti-ferritin antibody (data not shown). Thus, as dem-
onstrated for sCJD [7], PrPSc and ferritin form a complex
in CWD brain homogenates.
DE treated CWD and sheep scrapie are transported across 
Caco-2 monolayers
Although ferritin iron from distant species is taken up
efficiently by human intestinal epithelium [30,31], recep-
tors specific for the uptake of ferritin have not been
described. Nevertheless, PrPSc-ferritin complex from
sCJD brain homogenates is transported across a mono-
layer of Caco-2 cells [7], suggesting that a similar phe-
nomenon may occur for sheep scrapie and CWD prions.
T o evaluate this possibility, equal aliquots of DE treated
samples from scrapie sheep and two cases of CWD were
added to the apical (AP) chamber of a tight monolayer of
Caco-2 cells cultured on filter inserts (Figure 1C). Follow-
ing an overnight incubation at 37°C, culture medium
from the AP and basolateral (BL) chambers was har-
vested, and precipitated proteins were fractionated by
SDS-PAGE and transferred to a PVDF membrane. Prob-
ing for PrP reveals significant transport of DE-resistant
PrPSc from sheep, CWD-1, and CWD-2 homogenates
from the AP to the BL chamber (Figure 1D, lanes 1-6).
Reprobing of the membrane for ferritin shows similar
transport of ferritin to the BL chamber in all three sam-
ples (Figure 1D, lanes 1-6). To rule out possible leakage of
proteins from AP to the BL chamber, resistance across fil-
ters supporting Caco-2 monolayers was checked before
and after completion of the experiment, and the mono-
layers were stained for ZO-1, a tight junction protein, to
confirm the integrity of tight junctions throughout the
experimental procedure (Figure 1E, panels 1 and 2).
Together, these results demonstrate that a significant
amount of PrPSc from scrapie infected sheep and CWD
affected deer escapes digestion and is associated with fer-
ritin. More importantly, ferritin and PrPSc from both spe-
cies are transported across a monolayer of human Caco-2
cells, indicating that the species barrier against animal
prions or ferritin is not stringent enough to block trans-
port across these cells.Sunkesula et al. Molecular Brain 2010, 3:14
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Figure 1 DE resistant CWD and sheep scrapie are transported across Caco2 monolayers. (A) CWD and sheep scrapie brain homogenates were 
treated with DE and subjected to immunoblotting. Probing for PrP reveals DE-resistant PrP forms in all four cases of CWD and sheep scrapie (lanes 1-
8). (Lanes 1, 3, and 5 were loaded with 5 μl of each sample, lanes 2, 4, and 6 with 10 μl of the same sample, and lanes 7 and 8 with 15 μl of sample to 
confirm efficient cleavage of PrPSc). (B) Control and DE treated NH, CJDH, and CDW-4 samples were immunoprecipitated with anti-ferritin antibody 
and antibody-protein complexes eluted from beads and unbound proteins in the supernatant were subjected to Western blotting. Probing for PrP 
shows significant co-immunoprecipitation of PrP with ferritin from DE+ CJDH and CWD-4 samples (lanes 8 and 12). No PrP is detected in DE+ NH 
samples as expected (lanes 3 and 4, *) and in the supernatant of DE+ CJDH and CWD-4 samples (lanes 7 and 11). Significant amounts of normal PrP 
and full-length PrPSc co-immunoprecipitate with ferritin from DE- NH, CJDH, and CWD-4 samples (lanes 2, 6 and 10). (C) Model of a trans-well demon-
strating the separation of AP and BL chambers by a monolayer of Caco-2 cells. (D) DE treated brain homogenates from sheep, CWD-1, and CWD-2 
were re-suspended in PBS and added to the AP chamber of a tight monolayer of Caco-2 cells. After an overnight incubation, proteins from AP and BL 
chambers were precipitated and subjected to Western blotting. Probing for PrP shows significant transport of DE resistant PrPSc from sheep, CWD-1 
and CWD-2 samples to the BL chamber (lanes 1-6). Re-probing for ferritin shows similar transport of ferritin from AP to the BL chamber (lanes 1-6). (E) 
Immunostaining of filter inserts for the tight junction protein ZO-1 shows an intact monolayer of Caco-2 cells with tight junctions (panels 1 and 2). 
Bar: 10 μm.Sunkesula et al. Molecular Brain 2010, 3:14
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Iron content of ferritin determines efficiency of transport 
across Caco-2 cells
Ferritin is a major iron storage protein ubiquitously pres-
ent in food products prepared from plant and animal
sources, raising the possibility that it could serve as a sig-
nificant source of dietary iron. Recent reports describe
uptake of ferritin through specific receptors on oligoden-
drocytes, circulating reticulocytes, activated T and B-
cells, HeLa cells, and K562 cells [32,33], implicating ferri-
tin as an iron delivery protein. Although the presence of
similar receptors on Caco-2 cells is not known, we dem-
onstrated co-transport of PrPSc and ferritin from sCJD
brain homogenates across Caco-2 cells, though the
underlying mechanism and whether ferritin or PrPSc
drives transport of the complex was not assessed.
To understand the role of ferritin in this process, trans-
port of untreated control and iron depleted ferritin across
a monolayer of Caco-2 cells was checked. To deplete
brain ferritin of iron, sCJD brain homogenates prepared
in PBS were treated with iron chelator Desferrioxamine
(DFO) for one hour, followed by extensive dialysis of
untreated (-DFO) and DFO treated (+DFO) samples
against PBS. To check the extent of iron depletion, a small
aliquot of dialyzed samples was spotted on a PVDF mem-
brane and reacted for iron [26,34,35]. DFO treated sam-
ple shows a significant reduction in total iron compared
to untreated sample, confirming the chelating effect of
DFO (Figure 2A, panels 1 and 2). Subsequently, both sam-
ples were treated with proteinase-K (PK) to enrich for
ferritin [7]. Most proteins besides ferritin are degraded by
this treatment, including disease associated PrPSc that
becomes sensitive to PK following iron depletion [34].
PK-treated samples were checked again for iron content,
and no further change was observed by this treatment
(Figure 2A, panels 3 and 4). Residual proteins were pre-
cipitated with methanol and resuspended in PBS before
adding equal amounts of -DFO and +DFO samples to the
AP chamber of Caco-2 cell monolayers. Following an
overnight incubation, medium from both chambers was
collected, and methanol precipitated proteins were
resolved by SDS-PAGE followed by Western blotting.
Reaction with anti-ferritin antibody shows significantly
more transport of ferritin from -DFO sample to the BL
chamber compared to the +DFO sample (Figure 2B, lanes
1-4). However, the overall transport of ferritin from AP to
the BL chamber is ~5%, suggesting that majority of added
ferritin is not transcytosed by these cells. The integrity of
Caco-2 monolayers was confirmed as in Figure 1 above
before and after completion of the experiment by check-
ing resistance across the monolayer and immunostaining
for ZO-1 (Figure 2C, panels 1 and 2).
Brain ferritin is internalized by neuroblastoma cells
To evaluate whether neuroblastoma cells show similar
selectivity for iron rich ferritin uptake as Caco-2 cells,
normal human brain homogenate was treated with DFO
and PK as above. Subsequently, equal amounts of metha-
nol precipitated proteins from -DFO and +DFO samples
resuspended in PBS were added to M17 cells cultured on
glass coverslips. After an incubation of 30 minutes at
37°C, cells were washed with PBS, fixed in paraformalde-
hyde, permeabilized, and immunostained with anti-ferri-
tin antibody followed by FITC-conjugated secondary
antibody. A representative image shows significantly
more uptake of -DFO treated ferritin by M17 cells relative
to +DFO treated sample (Figure 2D, panels 1 and 2).
Taken together, these results suggest that efficiency of
ferritin uptake by Caco-2 and neuroblastoma cells is
determined in part by its iron content. Subsequent exper-
iments were focused on confirming these results in vivo
in mouse models.
Ferritin iron is taken up by mouse intestine
To evaluate whether ferritin is taken up by mouse intesti-
nal epithelial cells, advantage was taken of the fact that
ferritin from mouse neuroblastoma cells (N2a) migrates
slower than mouse duodenal epithelial cell ferritin when
fractionated on a native gradient gel, allowing differentia-
tion between exogenously introduced N2a cell ferritin
and endogenous duodenal ferritin.
Thus, N2a cells were radiolabeled with 59FeCl3 and the
cell pellet was homogenized in PBS. The most abundant
protein labeled by this procedure is cellular ferritin. Con-
trol sample was prepared by adding same number of 59Fe
counts (59FeCl3) to unlabeled cell homogenate prepared
under similar conditions. Equal 59Fe counts from both
samples were introduced by gastric gavage to wild-type
mice, and following a chase of 4hours, first 10 cm of the
duodenum were harvested. Proximal 2 cm of the duode-
num were homogenized in lysis buffer, and a half of each
sample was precipitated with methanol to isolate total
proteins. The duodenum samples and an aliquot of 59Fe
labeled cell homogenate were fractionated on a native gel
and autoradiographed. Mice fed with 59FeCl3 mixed with
unlabeled homogenate show significantly more 59Fe in
duodenal epithelial ferritin than the ones fed 59Fe-labeled
cell homogenate, demonstrating significantly lower effi-
ciency of iron uptake from ferritin relative to 59FeCl3 (Fig-
ure 3A, lanes 1 and 3 vs. 2 and 4). The radioactive bands
in lanes 1-4 represent duodenal ferritin, not cellular ferri-
tin that shows a different migration on these gels (Figure
3A, lane 5). 59Fe incorporation in major organs of mice
fed 59FeCl3 or 59Fe-N2a ferritin show a similar deficiencySunkesula et al. Molecular Brain 2010, 3:14
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Figure 2 Iron rich ferritin is internalized by Caco2 and human neuroblastoma cells. (A) Reaction of DFO and PK treated brain homogenate for 
iron shows significant depletion in the DFO+ sample (panels 1-4). (B) Caco-2 monolayers were exposed to PK treated DFO- and DFO+ CJDH in the AP 
chamber. Following an overnight incubation, precipitated proteins from the AP and BL medium were subjected to Western blotting. Probing for fer-
ritin shows significantly more transport of ferritin to the BL chamber of -DFO sample relative to the +DFO sample (lanes 2 and 4). (C) Immunostaining 
of filter inserts for ZO-1 shows intact monolayer of Caco-2 cells with tight junctions (panels 1 and 2). Bar: 10 μm. (D) Human neuroblastoma cells (M17) 
were exposed to 5 μl of -DFO and +DFO NH sample re-suspended in PBS. Immunostaining of fixed, permeabilized cells with anti-ferritin antibody fol-
lowed by FITC-conjugated secondary antibody shows prominent reaction for ferritin in intracellular structures consistent with endosomes (panels 1 
and 2). Reaction for ferritin is stronger in cells exposed to -DFO sample compared to +DFO exposed cells (panels 1 and 2). Bar: 10 μm. Inset shows 
enlarged image of the boxed area.Sunkesula et al. Molecular Brain 2010, 3:14
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of iron incorporation by the brain, liver, and spleen of
mice fed 59Fe-N2a ferritin, consistent with uptake from
the intestine (Fig 3B). Since duodenal samples do not
show the slower migrating N2a ferritin band, either iron
from N2a ferritin is released in the intestinal lumen
before uptake by duodenal epithelial cells, or cellular fer-
ritin donates its iron to duodenal epithelial ferritin rela-
tively soon after uptake by these cells. It is also possible
that both processes function concomitantly.
To distinguish between these possibilities, brain homo-
genate from scrapie infected mice was biotinylated with
sulfo-NHS-biotin overnight at 4°C and treated with PK to
enrich for ferritin and PrPSc. Methanol precipitated pro-
teins were resuspended in PBS and introduced to wild-
type mice by gastric gavage. Control mice received the
same volume of PBS. Following a chase of 2h, first 10 cm
of the duodenum were harvested and processed for
immunostaining. Reaction of sections with fluorescent
streptavidin shows significant uptake of biotin tagged
material by the duodenal epithelium (Figure 4A, panel 1,
arrow-heads). Duodenal lumen (marked by @) shows
similar streptavidin reactive material before internaliza-
tion (panel 1, arrow). Immunoreaction with anti-ferritin
antibody followed by FITC-tagged secondary antibody
shows co-localization of ferritin and streptavidin within
epithelial cells, indicating uptake of externally introduced
ferritin (Figure 4A, panels 2 and 3, arrow-heads). Reac-
tion for endogenous ferritin is also detected in epithelial
cells (Figure 4A, panel 2, *). Immunoreaction of adjacent
sections for ZO-1 shows intact tight junctions, ruling out
non-specific uptake of ferritin by these cells (Figure 4B).
Staining with hematoxylin and eosin demonstrates opti-
mal preservation of duodenal epithelium under these
experimental conditions (Figure 4C). Similar results were
obtained with hamster brain ferritin.
Iron depletion reduces efficiency of ferritin uptake by 
mouse intestinal epithelium
The influence of iron content of ferritin on its uptake by
mouse intestinal epithelial cells was checked by depleting
iron from scrapie infected mouse brain homogenate as
described above with DFO. Precipitated proteins from -
DFO +DFO samples were re-suspended in PBS and intro-
duced by gastric gavage to three sets of wild type mice
starved overnight to deplete endogenous ferritin. Follow-
ing a chase of 2 hours, first 10 cm of the duodenum were
processed for immunostaining as above. Immunoreaction
with antibody to ZO-1 followed by anti-mouse TRIT C
shows intact tight junctions along the luminal surface of
duodenal epithelium (Figure 5, panels 2, 4, 5, and 6,
arrows). Other sections show deeper areas highlighting
intestinal crypts (Figure 5, panels 1 and 3). Reaction for
ferritin followed by anti-rabbit-FITC shows significantly
more uptake of ferritin from -DFO sample relative to the
+DFO sample (Figure 5, panels 1-3 vs. 4-6, arrow-heads).
Notable reactivity for ferritin is observed in the intestinal
crypts of mice fed -DFO sample (Figure 5, panels 1 and 3,
arrow-heads), indicating transport of ferritin from the
epithelium to intestinal crypts. Intestinal crypts of mice
Figure 3 Ferritin iron is taken up and transported by duodenal 
epithelium. (A) Wild type mice were fed equal counts of 59FeCl3 mixed 
with unlabeled N2a cells (lanes 1 and 3) or 59Fe-labeled N2a cells (lanes 
2 and 4) and chased for 4 hours. Homogenates of duodenum (lanes 1 
and 2) or methanol precipitated protein from duodenum samples 
(lanes 3 and 4) were fractionated on a native gel and subjected to au-
toradiography (lanes 1-4). Lysates from 59Fe-labeled N2a cells were 
fractionated in parallel (lane 5). Significantly more 59Fe-ferritin is de-
tected in mice fed with 59FeCl3 relative to 59Fe-N2a homogenates 
(lanes 1 and 3 vs. 2 and 4). The 59Fe-ferritin signal is from duodenal fer-
ritin, not N2a ferritin (compare lanes 1-4 with lane 5). 59Fe-labeled 
transferrin (Tf) is also detected in the N2a sample (lane 5) [22,23](B) 
Quantification of 59Fe incorporated by brain, liver and spleen of these 
mice shows relatively less uptake by mice fed with 59Fe-labeled N2a 
homogenates relative to 59FeCl3. The data are representative of 3 inde-
pendent experiments.Sunkesula et al. Molecular Brain 2010, 3:14
http://www.molecularbrain.com/content/3/1/14
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Figure 4 Ferritin is endocytosed by duodenal enterocytes. (A) Immunostaining of duodenal sections from mice fed biotin tagged, PK-treated, 
scrapie infected mouse brain homogenates with streptavidin-Texas-red shows uptake of biotin tagged material by intestinal epithelial cells (panel 1, 
arrow-heads). Unabsorbed reactive material is detected in the intestinal lumen (panel 1, arrow, @). Co-immunostaining with rabbit-anti-ferritin anti-
body followed by goat anti-rabbit-FITC shows co-localization of streptavidin and ferritin reactive material (panels 2 and 3, arrow-heads). Endogenous 
mouse ferritin cross-reacts with the antibody and is detected in most epithelial cells (panel 2, *). Bar: 10 μm. Inset shows enlarged image of the boxed 
area. (B) Immunostaining of adjacent section with antibody to ZO-1 demonstrates intact tight junctions in these samples (arrow). (C) Staining with H 
& E shows optimal preservation of tissue under these experimental conditions.Sunkesula et al. Molecular Brain 2010, 3:14
http://www.molecularbrain.com/content/3/1/14
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Figure 5 Iron content of ferritin influences its uptake by duodenal enterocytes. Immunostaining of 3 wild type mice fed -DFO and +DFO treated 
scrapie infected mouse brain homogenate with antibody to ZO-1 followed by anti-mouse-TRITC secondary antibody shows intact tight junctions 
(panels 2 and 4-6, arrow). Other sections do not show the epithelial cell layer and lack ZO-1 reactivity (panels 1 and 3). Reaction with anti-ferritin anti-
body followed by anti-rabbit-FITC shows more uptake of -DFO ferritin compared to the +DFO sample (compare panels 1-3 with 4-6, arrow-heads). 
Most ferritin from -DFO sample accumulates in intestinal crypts after 4 hours of chase (panels 1 and 3). Three representative sections are shown from 
a total of 6 different experiments performed by three different individuals. Bar: 10 μm. Insets show enlarged image of boxed areas.Sunkesula et al. Molecular Brain 2010, 3:14
http://www.molecularbrain.com/content/3/1/14
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fed +DFO sample did not show any reactivity (data not
shown).
Discussion
Our data indicate that brain ferritin from deer, elk, and
sheep is transcytosed across a monolayer of human Caco-
2 epithelial cells, representing an in vitro model of human
intestinal epithelium. The efficiency of ferritin transport
is modulated by its iron content, suggesting that ferritin
serves as a biological source of iron. A similar selection
for iron-rich ferritin is noted in vivo in mice administered
iron depleted mouse brain homogenate. Since PrPSc and
ferritin form a complex in diseased brain homogenates
and resist degradation by digestive enzymes, these obser-
vations suggest that ferritin could serve as a mediator of
PrPSc transport across intestinal epithelial cells regardless
of homology between incoming PrPSc and host PrPC.
Previous attempts at understanding the mechanism of
PrPSc  transport across the intestinal epithelial barrier
have uncovered several possible pathways such as migrat-
ing dendritic cells and intestinal M cells [36]. The involve-
ment of laminin receptor (LRP/LR) dependent
endocytosis of PrPSc has also been described [37,38]. LRP
receptors have been identified on the intestinal brush
border, and ingested PrPSc has been reported to co-local-
ize with these receptors following ingestion. It is believed
that majority of ingested PrPSc loses infectivity following
digestion [39]. However, our observations suggest that
majority of PrPSc and ferritin in the ingested material
resist degradation by digestive enzymes, and are endocy-
tosed by intestinal epithelial cells. Ferritin by itself is
resistant to degradation and has been proposed as a
source of dietary iron [30,31,40]. Whether association of
PrPSc with ferritin increases its resistance to proteases in
unclear at this time, but raises the possibility of co-trans-
port with ferritin across the intestinal epithelium.
Regarding the uptake of ferritin, conflicting reports
suggest either direct uptake followed by release of associ-
ated iron somewhere along the endocytic pathway, or
release of iron in the intestinal lumen before uptake by
epithelial cells through the DMT1 pathway. In support of
the first hypothesis, receptors specific for ferritin uptake
have been described on oligodendrocytes [41], activated
B and T-cells, K562 cells, reticulocytes, and certain other
cell lines [33], suggesting that ferritin is a common source
of iron. Our observations indicate that ferritin is taken up
by intestinal epithelial cells and accumulates in intestinal
crypt cells before further transport or breakdown.
Although our data fall short of identifying a specific
receptor or demonstrating co-transport of PrPSc with fer-
ritin due to technical reasons, our previous observations
[7] and co-immunoprecipitation studies in this report
leave little doubt that PrPSc and ferritin form a complex,
and are likely to be co-transported across the intestinal
epithelium.
This possibility raises significant public health con-
cerns, especially due to the possibility of transmitting
CWD prions from infected deer and elk to cattle and to
the human food chain. Although PrPSc does not replicate
unless the host PrPC and incoming PrPSc share significant
homology, transport with ferritin could establish a carrier
state in non-homologous hosts, resulting in disease at a
later time. On the other hand, the association of PrPSc
with ferritin provides possible avenues to reduce expo-
sure and infectivity by chelating available iron in the
infected material. Such a treatment would have the com-
bined effect of decreased ferritin uptake and increased
degradation of PrPSc by digestive enzymes [this report,
[ 3 4 ] ] .  F u t u r e  r e s e a r c h  i s  n e c e s s a r y  t o  u n d e r s t a n d  t h e
mechanism of PrPSc-ferritin uptake by the intestine and
practical ways to reduce infectivity due to accidental
ingestion of PrPSc.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
SRBS and XL carried out mouse experiments, AS conducted the radioactive
iron feeding study and edited and revised the manuscript, and DD helped with
certain sections of the manuscript. All authors read and approved the final
manuscript.
Acknowledgements
Thanks are extended to Subhabrata Basu, Sushovita Mukherjee, Soumya 
Ghosh, and Yuehua Gao for participating in some of the experimental proce-
dures. This study was supported by grants R21AG033423 and R01NS044209 to 
NS from the National Institutes of Health.
Author Details
Department of Pathology, Wolstein Research Building, Case Western Reserve 
University, 2103 Cornell Road, Cleveland, OH- 44106, USA
References
1. Gajdusek DC, Zigas V: Degenerative diseases of the central nervous 
system in New Guinea: the endemic occurrence of "kuru" in the native 
population.  New Engl J Med 1957, 257:212-214.
2. Hadlow WJ: Kuru and Scrapie.  Lancet 1959, 2:289-290.
3. Hill AF, Desbruslais M, Joiner S, Sidle KC, Gowland I, Collinge J, Doey LJ, 
Lantos P: The same prion strain causes vCJD and BSE.  Nature 1997, 
389:448-450.
4. Brown P, Gibbs CJ, Rodgers-Johnson P, Asher DM, Sulima MP, Bacote A, 
Goldfarb LG, Gadjusek DC: Human spongiform encephalopathy.  Ann 
Neurol 1994, 35:513-529.
5. Taylor DM: Current perspectives on bovine spongiform 
encephalopathy and variant Creutzfeldt-Jakob disease.  Clin Microbiol 
Infect 2002, 8:332-339.
6. Huang FP, Farquhar CF, Mabbott NA, Bruce ME, MacPherson GG: 
Migrating intestinal dendritic cells transport PrP(Sc) from the gut.  J 
Gen Virol 2002, 83:267-271.
7. Mishra RS, Basu S, Gu Y, Luo X, Zou WQ, Mishra R, Li R, Chen SG, Gambetti 
P, Fujioka H, Singh N: Protease-resistant human prion protein and 
ferritin are co-transported across Caco-2 epithelial cells: implications 
for species barrier in prion uptake from the intestine.  J Neurosci 2004, 
24:11280-11290.
Received: 1 April 2010 Accepted: 29 April 2010 
Published: 29 April 2010
This article is available from: http://www.molecularbrain.com/content/3/1/14 © 2010 Sunkesula et al; licensee BioMed Central Ltd.  This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Molecular Brain 2010, 3:14Sunkesula et al. Molecular Brain 2010, 3:14
http://www.molecularbrain.com/content/3/1/14
Page 12 of 12
8. Heppner FL, Christ AD, Klein MA, Prinz M, Fried M, Kraehenbuhl JP, Aguzzi 
A: Transepithelial prion transport by M cells.  Nat Med 2001, 7:976-977.
9. Prusiner SB: Prions.  Proc Natl Acad Sci USA 1998, 95:13363-13383.
10. Aguzzi A, Calella AM: Prions: protein aggregation and infectious 
diseases.  Physiol Rev 2009, 89:1105-1152.
11. Collinge J: Variant Creutzfeldt-Jakob disease.  Lancet 1999, 354:317-323.
12. Bons N, Mestre-Fransces N, Belli P, Cathala F, Gajdusek DC, Brown P: 
Natural and experimental oral infection of non-human primates by 
bovine spongiform encephalopathy agents.  Proc Natl Acad Sci USA 
1999, 96:4046-4051.
13. d'Aignaux JNH, Cousens SN, Smith PG: Predictability of the UK variant 
Creutzfeldt-Jakob disease epidemic.  Science 2001, 294:1729-1730.
14. Miller MW, Williams ES, McCarty CW, Spraker TR, Kreeger TJ, Larsen CT, 
Thorne ET: Epizootiology of chronic wasting disease in free-ranging 
cervids in Colorado and Wyoming.  J Wildl Dis 2000, 36:676-690.
15. Lasmezas CI, Fournier JG, Nouvel V, Boe H, Marce D, Lamoury F, Kopp N, 
Hauw JJ, Ironside J, Bruce M, Dormont D, Deslys JP: Adaptation of the 
bovine spongiform encephalopathy agent to primates and 
comparison with Creutzfeldt-Jakob disease: Implications for human 
health.  Proc Natl Acad Sci USA 2001, 98:4142-4147.
16. Bonetta L: CWD research increases as US concern grows.  Nat Med 2002, 
12:1338.
17. Hill AF, Joiner S, Linehan J, Desbruslais M, Lantos PL, Collinge J: Species-
barrier-independent prion replication in apparently resistant species.  
Proc Natl Acad Sci USA 2000, 97:10248-10253.
18. Cereijido M, Robbins ES, Dolan ES, Rotunno WJ, Sabatini DD: Polarized 
monolayers formed by epithelial cells on a permanent translucent 
support.  J Cell Biol 1978, 77:853-880.
19. Peterson MD, Mooseker MS: Characterization of the enterocyte-like 
brush border cytoskeleton of the C2BBe clones of the human intestinal 
cell line, Caco-2.  J Cell Sci 1992, 102:581-600.
20. Race R, Meade-White K, Raines A, Raymond GJ, Caughey B, Chesebro B: 
Subclinical scrapie infection in a resistant species: persistence, 
replication, and adaptation of infectivity during four passages.  J Infect 
Dis 2002, 186:S166-170.
21. Race R, Raines A, Raymond GJ, Caughey B, Chesebro B: Long-term 
subclinical carrier state precedes scrapie replication and adaptation in 
a resistant species: analogies to bovine spongiform encephalopathy 
and variant Creutzfeldt-Jakob disease in humans.  J Virol 2001, 
75:10106-10112.
22. Singh A, Kong Q, Luo X, Petersen RB, Meyerson H, Singh N: Prion protein 
(PrP) knock-out mice show altered iron metabolism: a functional role 
for PrP in iron uptake and transport.  PLoS One 2009, 4:e6115.
23. Singh A, Mohan ML, Isaac AO, Luo X, Petrak J, Vyoral D, Singh N: Prion 
protein modulates cellular iron uptake: a novel function with 
implications for prion disease pathogenesis.  PLoS One 2009, 4:e4468.
24. Vyoral D, Petrák J, Hradilek A: Separation of cellular iron containing 
compounds by electrophoresis.  Biol Trace Elem Res 1998, 61:263-275.
25. Gu Y, Verghese S, Bose S, Mohan M, Singh N: Mutant prion protein 
D202N associated with familial prion disease is retained in the 
endoplasmic reticulum and forms 'curly' intracellular aggregates.  J Mol 
Neurosci 2007, 32:90-96.
26. Smith MA, Harris PL, Sayre LM, Perry G: Iron accumulation in Alzheimer 
disease is a source of redox-generated free radicals.  Proc Natl Acad Sci 
USA 1997, 94:9866-9868.
27. Jin T, Gu Y, Zanusso G, Sy M, Kumar A, Cohen M, Gambetti P, Singh N: The 
chaperone protein BiP binds to a mutant prion protein and mediates 
its degradation by the proteasome.  J Biol Chem 2000, 275:38699-38704.
28. Gu Y, Fujioka H, Mishra RS, Li R, Singh N: Prion peptide 106-126 
modulates the aggregation of cellular prion protein and induces the 
synthesis of potentially neurotoxic transmembrane PrP.  J Biol Chem 
2002, 277:2275-2286.
29. Glahn RP, Lee OA, Yeung A, Goldman MI, Miller DD: Caco-2 cell ferritin 
formation predicts nonradiolabeled food iron availability in an in vitro 
digestion/Caco-2 cell culture model.  J Nutr 1998, 128:1555-1561.
30. Lönnerdal B, Bryant A, Liu X, Theil EC: Iron absorption from soybean 
ferritin in nonanemic women.  Am J Clin Nutr 2006, 83:103-107.
31. Davila-Hicks P, Theil EC, Lönnerdal B: Iron in ferritin or in salts (ferrous 
sulfate) is equally bioavailable in nonanemic women.  Am J Clin Nutr 
2004, 80:936-940.
32. Todorich B, Zhang X, Slagle-Webb B, Seaman WE, Connor JR: Tim-2 is the 
receptor for H-ferritin on oligodendrocytes.  J Neurochem 2008, 
107:1495-1505.
33. Li L, Fanga CJ, James C, Ryan JC, Niemi EC, Lebrón JA, Björkman PJ, Arase 
H, Torti FM, Torti SV, Nakamura MC, Seaman WE: Binding and uptake of 
H-ferritin are mediated by human transferrin receptor-1.  Proc Natl Acad 
Sci USA 2010, 107:3505-3510.
34. Basu S, Mohan ML, Luo X, Kundu B, Kong Q, Singh N: Modulation of 
proteinase K-resistant prion protein in cells and infectious brain 
homogenate by redox iron: implications for prion replication and 
disease pathogenesis.  Mol Biol Cell 2007, 18:3302-3312.
35. Singh A, Isaac AO, Luo X, Mohan ML, Cohen ML, Chen F, Kong Q, Bartz J, 
Singh N: Abnormal brain iron homeostasis in human and animal prion 
disorders.  PLoS Pathog 2009, 5:e1000336.
36. Mabbott NA, MacPherson GG: Prions and their lethal journey to the 
brain.  Nat Rev Microbiol 2006, 4:201-211.
37. Morel E, Andrieu T, Casagrande F, Gauczynski S, Weiss S, Grassi J, Rousset 
M, Dormont D, Chambaz J: Bovine prion is endocytosed by human 
enterocytes via the 37 kDa/67 kDa laminin receptor.  Am J Pathol 2005, 
167:1033-1042.
38. Ghosh S: Mechanism of intestinal entry of infectious prion protein in 
the pathogenesis of variant Creutzfeldt-Jakob disease.  Adv Drug Deliv 
Rev 2004, 56:915-920.
39. Jeffrey M, González L, Espenes A, Press CM, Martin S, Chaplin M, Davis L, 
Landsverk T, MacAldowie C, Eaton S, McGovern G: Transportation of 
prion protein across the intestinal mucosa of scrapie-susceptible and 
scrapie-resistant sheep.  J Pathol 2006, 209:4-14.
40. Kalgaonkar S, Lönnerdal B: Effects of dietary factors on iron uptake from 
ferritin by Caco-2 cells.  J Nutr Biochem 2008, 19:33-39.
41. Hulet SW, Heyliger SO, Powers S, Connor JR: Oligodendrocyte progenitor 
cells internalize ferritin via clathrin-dependent receptor mediated 
endocytosis.  J Neuron Res 2000, 61:52-60.
doi: 10.1186/1756-6606-3-14
Cite this article as: Sunkesula et al., Iron content of ferritin modulates its 
uptake by intestinal epithelium: implications for co-transport of prions 
Molecular Brain 2010, 3:14